Ubs Global Asset Management Americas »

Xenon Pharmaceuticals shares owned by Ubs Global Asset Management Americas

Quarter-by-quarter ownership of Xenon Pharmaceuticals (XENE) shares owned by Ubs Global Asset Management Americas from 13F filings

Historical chart of Ubs Global Asset Management Americas investment in Xenon Pharmaceuticals

202120222023202420252M4M6M8M0100k200k300k
Value ($)Share countHistorical XENE position of Ubs Global Asset … Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Xenon Pharmaceuticals held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xenon Pharmaceuticals by Ubs Global Asset Management Americas

Quarter filed Position value Share count Share price at filing
2024-12-31 $7.5M 192k 39.20
2024-09-30 $6.4M 163k 39.37
2024-06-30 $6.3M 163k 38.99
2024-03-31 $3.3M 78k 43.05
2023-12-31 $3.6M 78k 46.06
2023-09-30 $2.4M 69k 34.16
2023-06-30 $1.9M 53k 35.79
2023-03-31 $1.9M 53k 35.79
2022-12-31 $1.5M 39k 39.43
2022-09-30 $1.4M 38k 36.10
2022-06-30 $819k 27k 30.42
2022-03-31 $882k 29k 30.57
2021-12-31 $877k 28k 31.24
2021-06-30 $5.9M 319k 18.62
2021-03-31 $6.0M 335k 17.90
2020-12-31 $4.1M 368k 11.07
2020-09-30 $4.1M 368k 11.07
2020-06-30 $4.6M 365k 12.54